Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $62.8900 (-7.32%) ($62.8900 - $62.8900) on Thu. Nov. 3, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.7% (three month average) | RSI | 22 | Latest Price | $62.8900(-7.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -5.6% a day on average for past five trading days. | Weekly Trend | LGND declines -7.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(44%) IWN(44%) IWO(43%) IWC(41%) SDY(39%) | Factors Impacting LGND price | LGND will decline at least -1.85% in a week (0% probabilities). VXX(-16%) UNG(-9%) UUP(-7%) EDOC(-5%) TBT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.85% (StdDev 3.7%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $86.7 | 5 Day Moving Average | $78.22(-19.6%) | 10 Day Moving Average | $82.13(-23.43%) | 20 Day Moving Average | $86.7(-27.46%) | To recent high | -41.6% | To recent low | 0% | Market Cap | $1.011b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |